Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension

Hypertension

Volumn 28, Issue 4, 1996, Pages 652-655

  Ergul, Sitki ^a   Parish, David C ^a   Puett, David ^b   Ergul, Adviye ^b  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Georgia ^*  (United States)

Author keywords

blood pressure; endothelin; gender; hypertension, essential; race

Indexed keywords

ENDOTHELIN 1;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY FAILURE; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; STROKE; VASOCONSTRICTION;

EID: 0029797408     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.4.652     Document Type: Article

References (25)

1. Vane JR, Anggard EE, Botting RM. Mechanism of disease: regulatory functions of the vascular endothelium. N Engl J Med. 1990; 323:27-36.
2. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988; 332:411-415.
3. Hahn AJ, Resnik TJ, Burden TS, Powell T, Dohi V, Buhler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1990;1:649-659.
4. Glassberg MK, Ergul A, Wanner A, Puett D. Endothelin promotes mitogenesis in airway smooth muscle cells. Am J Respir Cell Mol Biol. 1994;10:316-321.
5. Kawaguchi H, Sawa H, Yasuda H. Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary endothelial cells. J Mol Cell Cardiol. 1990;22:839-842.
6. Cozza EN, Gomez-Sanchez CE, Foecking MF, Chioiu S. Endothelin binding of cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest. 1989;84:1032-1035.
7. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994;46:325-415.
8. Stewart DJ, Levy RD, Cernacek P. Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991;114:464-469.
9. Lerman A, Edwards BS, Hallet JW, Heublein DM, Sandberg SM, Burnett SMJ. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325:997-1001.
10. Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, Teragaki M, Oku H, Takeuchi K, Takeda T. Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J. 1990;119:801-806.
11. Polderman KH, Steouwer CDA, van Kamp GP, Dekker GA, Verheugt FWA, Gooren LJG. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 1993;118:429-432.
12. Miyauchi T, Yanagisawa M, Iida K, Ajisaka R, Suzukii N, Fujino M, Goto K, Masaki T, Sugishita Y. Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J. 1992;123:1092-1093.
13. Gillum RF. Pathophysiology of hypertension in blacks and whites. Hypertension. 1979;1:468-475.
14. Cooper ES, Kuller LH, Saunders E, Martinez-Maldonado M, Caplan LR, Yatsu FM, Savage DD, Curry CL, Yu PN, Shulman NB, Hall WD. Special report. Cardiovascular diseases and stroke in African-Americans and other racial minorities in the United States: a statement of health professionals. Circulation. 1991;83:1462-1480.
15. Parish DC, Klekamp J, Wynn LJ, Dane FC, Smith MU, D'Amato PH. Arteriographic incidence of coronary artery disease in black men with chest pain. South Med J. 1994;87:33-37.
16. Masaki T. Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol. 1995;35:235-255.
17. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med. 1990;88:614-618.
18. Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med. 1990;322:205-209.
19. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension. 1990;15:493-496.
20. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH. Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens. 1992;5:161-166.
21. Jeunemaitre X, Soubrier F, Kotelevtev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
22. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH, The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95:948-953.
23. Takeshita H, Nishikibe M, Yano M, Ikemoto F. Coronary vascular response to endothelin in isolated perfused hearts of spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1991;18:661-669.
24. Yasujima M, Abe K, Kanazawa M, Yoshida K, Kohzuki M, Takeuchi K, Tsunoda K, Kudo K, Hiwatari M, Sato T. Antihypertensive effect of captopril and enalapril in endothelin infused rats. Tohoku J Exp Med. 1991;163:219-227.
25. Scott-Burden T, Resink TJ, Hahn AW, Vanhoutte PM. Induction of endothelin secretion by angiotensin II: effects on growth and synthetic activity of vascular smooth muscle cells. J Cardiovasc Pharmacol. 1991;17:S96-S100.